351 related articles for article (PubMed ID: 12038667)
1. Iron hydroxide polymaltose: iatrogenic cause of persistent iron deficiency anaemia despite continuous oral iron therapy.
Mehta BC
J Assoc Physicians India; 2002 Feb; 50():279-80. PubMed ID: 12038667
[No Abstract] [Full Text] [Related]
2. Oral iron.
Nurs Times; 2006 Jun 27-Jul 3; 102(26):40. PubMed ID: 16845816
[No Abstract] [Full Text] [Related]
3. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy.
Khalafallah A; Dennis A; Bates J; Bates G; Robertson IK; Smith L; Ball MJ; Seaton D; Brain T; Rasko JE
J Intern Med; 2010 Sep; 268(3):286-95. PubMed ID: 20546462
[TBL] [Abstract][Full Text] [Related]
4. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.
Van Wyck DB; Mangione A; Morrison J; Hadley PE; Jehle JA; Goodnough LT
Transfusion; 2009 Dec; 49(12):2719-28. PubMed ID: 19682342
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of oral and intravenous iron therapy in haemodialysis patients.
Jenq CC; Tian YC; Wu HH; Hsu PY; Huang JY; Chen YC; Fang JT; Yang CW
Int J Clin Pract; 2008 Mar; 62(3):416-22. PubMed ID: 17511797
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of efficacy and safety of iron polymaltose complex and folic acid (Mumfer) vs iron formulation (ferrous fumarate) in female patients with anaemia.
Reddy PS; Adsul BB; Gandewar K; Korde KM; Desai A
J Indian Med Assoc; 2001 Mar; 99(3):154-5. PubMed ID: 11478761
[TBL] [Abstract][Full Text] [Related]
7. Ferrous sulfate versus iron polymaltose complex for treatment of iron deficiency anemia in children.
Bopche AV; Dwivedi R; Mishra R; Patel GS
Indian Pediatr; 2009 Oct; 46(10):883-5. PubMed ID: 19430060
[TBL] [Abstract][Full Text] [Related]
8. [Iron protein-succinylate in the treatment of adult iron-deficiency anemia].
Pujol Farriols R; Anglada Oriol M; Formiga Pérez F; Fernández-Sabe N; Mitjavila Vileró F; Vidaller Palacín A
An Med Interna; 2002 Dec; 19(12):651-2. PubMed ID: 12593038
[No Abstract] [Full Text] [Related]
9. Are ferric compounds useful in treatment of iron deficiency anemia?
Arvas A; Gür E
Turk J Pediatr; 2000; 42(4):352-3. PubMed ID: 11196760
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Therapeutic Effects and Side Effects of Oral Iron Supplements in Iron Deficiency Anemia.
Wu TW; Tsai FP
Drug Res (Stuttg); 2016 May; 66(5):257-61. PubMed ID: 26697889
[TBL] [Abstract][Full Text] [Related]
11. A comparison between intravenous iron polymaltose complex (Ferrum Hausmann) and oral ferrous fumarate in the treatment of iron deficiency anaemia in pregnancy.
Singh K; Fong YF; Kuperan P
Eur J Haematol; 1998 Feb; 60(2):119-24. PubMed ID: 9508353
[TBL] [Abstract][Full Text] [Related]
12. Mumfer (iron polymaltose complex) in the management of anaemia in pregnancy--an Indian study.
Reddy PS; Adsul BB; Gandewar K; Desai A
J Indian Med Assoc; 2000 Jun; 98(6):343, 346. PubMed ID: 11203059
[No Abstract] [Full Text] [Related]
13. Iron supplementation in pregnancy--does the preparation matter?
Melamed N; Ben-Haroush A; Kaplan B; Yogev Y
Arch Gynecol Obstet; 2007 Dec; 276(6):601-4. PubMed ID: 17541618
[TBL] [Abstract][Full Text] [Related]
14. A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial.
Birgegård G; Henry D; Glaspy J; Chopra R; Thomsen LL; Auerbach M
Pharmacotherapy; 2016 Apr; 36(4):402-14. PubMed ID: 26927900
[TBL] [Abstract][Full Text] [Related]
15. Letter to the editor: treatment of iron deficiency anemia.
Ozsoylu S
Pediatr Hematol Oncol; 2005; 22(7):645-6; author reply 647-8. PubMed ID: 16166057
[No Abstract] [Full Text] [Related]
16. Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy.
al-Momen AK; al-Meshari A; al-Nuaim L; Saddique A; Abotalib Z; Khashogji T; Abbas M
Eur J Obstet Gynecol Reprod Biol; 1996 Nov; 69(2):121-4. PubMed ID: 8902444
[TBL] [Abstract][Full Text] [Related]
17. Iron polymaltose versus ferrous gluconate in the prevention of iron deficiency anemia of infancy.
Jaber L; Rigler S; Taya A; Tebi F; Baloum M; Yaniv I; Haj Yehia M; Tamary H
J Pediatr Hematol Oncol; 2010 Nov; 32(8):585-8. PubMed ID: 20930652
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of iron from oral ferric polymaltose in humans.
Nielsen P; Gabbe EE; Fischer R; Heinrich HC
Arzneimittelforschung; 1994 Jun; 44(6):743-8. PubMed ID: 8053973
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of tolerability and efficacy of iron protein succinylate versus iron hydroxide polymaltose complex in the treatment of iron deficiency in children.
Haliotis FA; Papanastasiou DA
Int J Clin Pharmacol Ther; 1998 Jun; 36(6):320-5. PubMed ID: 9660039
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of iron(III)-hydroxide polymaltose complex / a review of over 25 years experience.
Geisser P
Arzneimittelforschung; 2007; 57(6A):439-52. PubMed ID: 17691594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
